Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways

Publication date: 24 April 2021Source: Journal of Ethnopharmacology, Volume 270Author(s): Zheng Wang, Wen Chen, Yunying Li, Shuying Zhang, He Lou, Xiaoyan Lu, Xiaohui Fan
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research